Zhang, Huai, Targher, Giovanni and Byrne, Chris , (2024) A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease. Hepatology International, 18 (4), 1178-1201.
Abstract
Background: with the implementation of the 11th edition of the International
Classification of Diseases (ICD-11) and publication of the metabolic dysfunction associated fatty liver disease (MAFLD) nomenclature in 2020, it is important to establish consensus for the coding of MAFLD in ICD-11. This will inform subsequent revisions of ICD-11.
Methods: using the Qualtrics XM and WJX platforms, questionnaires were sent
online to MAFLD-ICD-11 coding collaborators, authors of papers, and relevant
association members.
Results: a total of 890 international experts in various fields from 61 countries
responded to the survey. We also achieved full coverage of provincial-level
administrative regions in China. 77.1% of respondents agreed that MAFLD should be represented in ICD-11 by updating NAFLD, with no significant regional differences (77.3% in Asia and 76.6% in non-Asia, p=0.819). Over 80% of respondents agreed or somewhat agreed with the need to assign specific codes for progressive stages of MAFLD (i.e. steatohepatitis) (92.2%), MAFLD combined with comorbidities (84.1%), or MAFLD subtypes (i.e., lean, overweight/obese, and diabetic) (86.1%).
Conclusions: this global survey by a collaborative panel of clinical, coding, health
management and policy experts, indicates agreement that MAFLD should be coded in ICD-11. The data serves as a foundation for corresponding adjustments in the ICD-11 revision.
More information
Identifiers
Catalogue record
Export record
Contributors
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.